Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant

By sjmartinez • November 19, 2024

Walther FJ, Waring AJ. Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol. 2024 Dec 1;327(6):L883-L889. doi: 10.1152/ajplung.00186.2024. Epub 2024 Oct 15. PMID: 39404798.

Tags: aerosol delivery, Harbor UCLA, lung surfactant, nasal continuous positive airway pressure, peptide mimics, Publications, Pulmonary, Critical Care & Sleep Medicine, surfactant proteins B and C

HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort

Cascino K, Liechti T, Seaberg EC, Stevens KE, Wolinsky SM, Witt MD, Mailliard RB, Roederer M, Bailey J, Thio CL, Cox AL. HIV causes global[...]

AI-Derived LA Volume Index, LA/RA and LA/LV Volume Ratios From Coronary Artery Calcium Scans Predict Long-Term Atrial Fibrillation and Stroke

Azimi A, Atlas K, Reeves AP, Zhang C, Wasserthal J, Mirjalili SR, Mozafarybazargany M, Hashemi A, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, Branch[...]

Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O2 therapy

Adami A, Vitacca M, Casaburi R, Salvi B, Simonelli C, Rossiter HB, Paneroni M. Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by[...]